Niaspan Dosage
Links shared publicly online about this topic
Efficacy of Abbott cholesterol drug in question
news-medical.net — “A latest study has found that using medication to raise good cholesterol while lowering the bad does NOT translate into fewer adverse cardiovascular events like heart attacks and strokes. The study was revealed Thursday by the National Institutes of Health and it found that high dosages of Abbott Laboratories' Niaspan failed to prevent heart attacks and boosted the likelihood of a stroke when combined with the popular generic cholesterol pill Simvastatin, also known under the brand name Zoco” View full resource at news-medical.net
Most Recently Shared on May 29, 2011 at 11:30 pm By:
Stroke News: Efficacy of Abbott cholesterol drug in question: A latest study has found that using medication t... http://twurl.nl/gcfxn5
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
News-Medical.Net
Stay up to date with the latest Stroke news and research via News-Medical.Net
Advertisement
